A new diagnostic test for VLCAD deficiency using immunohistochemistry.

Y Ohashi1, Y Hasegawa, K Murayama

  • 1Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan.

Neurology
|June 24, 2004
PubMed
Summary

A new immunohistochemical method efficiently detects very-long-chain acyl-CoA dehydrogenase (VLCAD) deficiency. This technique identified 13 new Japanese patients with VLCAD deficiency, aiding diagnosis in metabolic myopathy cases.